Internal Medicine, Endocrinology, Diabetes, & Metabolism · Cayey, PR
NPI
1902078157
Since 2008
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
109 Ave Jose de Diego E
Cayey, PR, 00736
Phone (787) 635-4374
Groups this clinician bills Medicare through
Medicare paid, 2024
$5,799
82 services
Medicare patients, 2024
31
Average age 74
Drug cost, 2024
$2.7M
6,201 prescriptions
Company payments, 2025
$1,177
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marielba Agosto was code 99214 (office e&m - established), 40 times for 26 patients. In total Marielba Agosto billed 82 services in 10 codes, and Medicare paid $5,799.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-02-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 40 | 26 | $85.97 | $3,439 |
| 99213 Office E&M - Established | Office | 17 | 15 | $54.73 | $930 |
By year: 2022 $4,460 for 73 services; 2023 $5,740 for 81 services; 2024 $5,799 for 82 services.
Medicare prescription drug claims, 2024
In 2024, the drug Marielba Agosto prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 1,209 prescriptions and refills. In total Marielba Agosto wrote 6,201 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Synthroid Levothyroxine Sodium | 1,209 | 2,536 | 289 | $111K |
| Trijardy Xr Empaglifloz/Linaglip/Metformin | 413 | 708 | 101 | $429K |
| Metformin Hcl Generic | 320 | 914 | 115 | $2,468 |
| Rosuvastatin Calcium Generic | 265 | 769 | 100 | $4,545 |
| Atorvastatin Calcium Generic | 227 | 647 | 80 | $3,075 |
| Pioglitazone Hcl Generic | 222 | 652 | 71 | $5,673 |
| Ozempic Semaglutide | 219 | 296 | 45 | $275K |
| Levothyroxine Sodium Generic | 201 | 513 | 65 | $2,901 |
| Synjardy Xr Empagliflozin/Metformin Hcl | 187 | 345 | 51 | $208K |
| Trulicity Dulaglutide | 175 | 259 | 31 | $273K |
| Lantus Insulin Glargine,hum.Rec.Anlog | 174 | 387 | 53 | $38K |
| Farxiga Dapagliflozin Propanediol | 152 | 296 | 44 | $171K |
| Jardiance Empagliflozin | 124 | 248 | 33 | $149K |
| Xigduo Xr Dapaglifloz Propaned/Metformin | 111 | 243 | 29 | $139K |
| Janumet Xr Sitagliptin Phos/Metformin Hcl | 110 | 228 | 31 | $122K |
Brand drugs: 3,823 claims; generic drugs: 2,130 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marielba Agosto $1,177 ($1,177 in general payments such as food, travel and fees) from 8 companies. The largest payer was Amgen Inc. with $266.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.